Advertisement

Analytical and Bioanalytical Chemistry

, Volume 411, Issue 25, pp 6625–6635 | Cite as

Routine analytical method for monitoring the main metabolites for a recurrent group of parabens and pharmaceuticals in wastewater and tap water

  • José Luis Malvar
  • Juan Luis SantosEmail author
  • Julia Martín
  • Irene Aparicio
  • Esteban Alonso
Research Paper

Abstract

The presence of parabens and pharmaceuticals on the aquatic environment has been widely evaluated in the last years. Nevertheless, there is scarce information about the occurrence of their metabolites and/or degradation products in spite of the fact that they can be more toxic or more concentrated than their parent compounds. One of the main drawbacks for their monitoring is the lack of simple and reliable analytical methods for their routine determination. In this work, an analytical method has been developed and validated for the simultaneous extraction and determination of the main metabolites of the pharmaceuticals diclofenac, ibuprofen, sulfamethoxazole, carbamazepine and caffeine and of the parabens methylparaben and propylparaben and their parent compounds in wastewater and tap water samples. Sample extraction was carried out by conventional solid-phase extraction with OASIS HLB cartridges. Analytical determination was carried out by liquid chromatography-tandem mass spectrometry with electrospray ionization. Average accuracy was in the range from 66 to 120% in wastewater and from 86 to 120% in tap water. Precision, expressed as relative standard deviation, was lower than 17% for all the compounds. Method quantification limits were in the range from 1.0 to 33 ng L−1 in wastewater and from 0.5 to 28 ng L−1 in tap water. The method was applied to wastewater and tap water samples. None of the target compounds was detected in tap water whereas all of them were detected in wastewater. Concentrations of the metabolites were similar or higher than those of the parent compounds.

Graphical abstract

Keywords

Metabolites Pharmaceuticals Personal care products Aqueous samples Solid-phase extraction Mass spectrometry 

Notes

Funding information

This work was financially supported by the Spanish Ministry of Economy and Competitiveness (Project No. CTM2017-82778-R). J.L. Malvar acknowledges the predoctoral grants from the Spanish Ministry of Economy and Competitiveness (FPU17/00368) and from the University of Seville (VIPPIT-2018-II.2).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

216_2019_2035_MOESM1_ESM.pdf (278 kb)
ESM 1 (PDF 278 kb)

References

  1. 1.
    Błędzka D, Gromadzińska J, Wąsowicz W. Parabens. From environmental studies to human health. Environ Int. 2014;67:27–42.CrossRefGoogle Scholar
  2. 2.
    Haman C, Dauchy X, Rosin C, Munoz J. Occurrence, fate and behavior of parabens in aquatic environment: a review. Water Res. 2015;68:1–11.CrossRefGoogle Scholar
  3. 3.
    Miller TH, Bury NR, Owen SF, MacRae JI, Barron LP. A review of the pharmaceutical exposome in aquatic fauna. Environ Pollut. 2018;239:129–46.CrossRefGoogle Scholar
  4. 4.
    Tröger R, Klöckner P, Ahrens L, Wiberg K. Micropollutants in drinking water from source to tap – method development and application of a multiresidue screening method. Sci Total Environ. 2018;627:1404–32.CrossRefGoogle Scholar
  5. 5.
    López-Serna R, Petrović M, Barceló D. Occurrence and distribution of multi-class pharmaceuticals and their active metabolites and transformation products in the Ebro River basin (NE Spain). Sci Total Environ. 2012;440:280.CrossRefGoogle Scholar
  6. 6.
    Lai FY, Ort C, Gartner C, Carter S, Pricahard J, Kirkbride P, et al. Refining the estimation of illicit drug consumptions from wastewater analysis: co-analysis of prescription pharmaceuticals and uncertainty assessment. Water Res. 2011;45:4437–48.CrossRefGoogle Scholar
  7. 7.
    Senta I, Gracia-Lor E, Borsotti A, Zucatto E, Castiglioni S. Wastewater analysis to monitor use of caffeine and nicotine and evaluation of their metabolites as biomarkers for population size assessment. Water Res. 2015;74:23–33.CrossRefGoogle Scholar
  8. 8.
    Daughton CG. Monitoring wastewater for assessing community health: sewage chemical-information mining (SCIM). Sci Total Environ. 2018;619–620:748–64.CrossRefGoogle Scholar
  9. 9.
    Wang W, Kannan K. Fate of parabens and their metabolites in two wastewater treatment plants in New York State, United States. Environ Sci Technol. 2016;50:1174–81.CrossRefGoogle Scholar
  10. 10.
    Wild CO. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomark Prev. 2005;14:1847–50.CrossRefGoogle Scholar
  11. 11.
    Evgenidou EN, Konstantinou IK, Lambropoulou DA. Ocurrence and removal of transformation products of PPCPs and illicit drugs in wastewaters: a review. Sci Total Environ. 2015;505:905–26.CrossRefGoogle Scholar
  12. 12.
    Yin L, Wang B, Yuan H, Deng S, Huang J, Wang Y, et al. Pay special attention to the transformation products of PPCPs in environment. Emerg Contam. 2017;3:69–75.CrossRefGoogle Scholar
  13. 13.
    Fenet H, Mathieu O, Mahjoub O, Li Z, Hillaire-Buys D, Casellas C, et al. Carbamazepine, carbamazepine epoxide and dihydroxycarbamazepine sorption to soil and occurrence in a wastewater reuse site in Tunisia. Chemosphere. 2012;88:49–54.CrossRefGoogle Scholar
  14. 14.
    Bahlman A, Brack W, Schneider RJ, Krauss M. Carbamazepine and its metabolites in wastewater: analytical pitfalls and occurrence in Germany and Portugal. Water Res. 2014;57:104–14.CrossRefGoogle Scholar
  15. 15.
    He K, Yonetani T, Asada Y. Simultaneous determination of carbamazepine-N-glucuronide and carbamazepine phase I metabolites in the wastewater by liquid chromatography-tandem mass spectrometry. Microchem J. 2019;145:1191–8.CrossRefGoogle Scholar
  16. 16.
    Leclercq M, Mathieu O, Gomez E, Casellas C, Fenet H, Hillaire-Buys D. Presence and fate of carbamazepine, oxcarbazepine, and seven of their metabolites at wastewater treatment plants. Arch Environ Contam Toxicol. 2008;56:408–15.CrossRefGoogle Scholar
  17. 17.
    Stülten D, Zühlke S, Lamshöft M, Spiteller M. Occurrence of diclofenac and selected metabolites in sewage effluents. Sci Total Environ. 2008;405:310–6.CrossRefGoogle Scholar
  18. 18.
    Ferrando-Climent L, Collado N, Buttiglieri G, Gros M, Rodríguez-Roda I, Rodríguez-Mozaz S, et al. Comprehensive study of ibuprofen and its metabolites in activated sludge batch experiments and aquatic environment. Sci Total Environ. 2012;438:404–13.CrossRefGoogle Scholar
  19. 19.
    Boix C, Ibáñez M, Zamora T, Sancho JV, Niessen WMA, Hernández F. Identification of new omeprazole metabolites in wastewaters and surface waters. Sci Total Environ. 2014;468-469:706–14.CrossRefGoogle Scholar
  20. 20.
    He K, Echigo S, Asada Y, Itoh S. Determination of caffeine and its metabolites in wastewater treatment plants using solid-phase extraction and liquid chromatography-tandem mass spectrometry. Anal Sci. 2018;34:349–54.CrossRefGoogle Scholar
  21. 21.
    Krizman-Matasic I, Kostanjevecki P, Ahel M, Terzic S. Simultaneous analysis of opioid analgesics and their metabolites in municipal wastewaters and river water by liquid chromatography–tandem mass spectrometry. J Chromatogr A. 2018;1533:102–11.CrossRefGoogle Scholar
  22. 22.
    González Alonso S, Catalá M, Romo R, Rodríguez JL, Gil de Miguel A, Valcárcel Y. Pollution by psychoactive pharmaceuticals in the Rivers of Madrid metropolitan area (Spain). Environ Int. 2010;36:195–201.CrossRefGoogle Scholar
  23. 23.
    Larsson E, Al-Hamimi S, Jönsson JA. Behaviour of nonsteroidal anti-inflammatory drugs and eight of their metabolites during wastewater treatment studied by hollow fibre liquid phase microextraction and liquid chromatography mass spectrometry. Sci Total Environ. 2014;485-486:300–8.CrossRefGoogle Scholar
  24. 24.
    Karthikraj R, Vasu AK, Balakrishna K, Sinha RK, Kannan K. Occurrence and fate of parabens and their metabolites in five sewage treatment plants in India. Sci Total Environ. 2017;593-594:592–8.CrossRefGoogle Scholar
  25. 25.
    Hermes N, Jewell KS, Wick A, Ternes TA. Quantification of more than 150 micropollutants including transformation products in aqueous samples by liquid chromatography-tandem mass spectrometry using scheduled multiple reaction monitoring. J Chromatogr A. 2018;1531:64–73.CrossRefGoogle Scholar
  26. 26.
    Capello C, Fischer U, Hungerbühler K. What is a green solvent? A comprehensive framework for the environmental assessment of solvents. Green Chem. 2007;9:927–34.CrossRefGoogle Scholar
  27. 27.
    Commission Decision 2002/657/EC of August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off J Eur Commun L221, 8–36.Google Scholar
  28. 28.
    Arbeláez P, Borrull F, Marcé RM, Pocurull E. Trace-level determination of sweeteners in sewage sludge using selective pressurized liquid extraction and liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2015;1408:15–21.CrossRefGoogle Scholar
  29. 29.
    Gracia-Lor E, Ibáñez M, Zamora T, Sancho JV, Hernández F. Investigation of pharmaceutical metabolites in environmental waters by LC-MS/MS. Environ Sci Pollut Res. 2014;21:5496–510.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • José Luis Malvar
    • 1
  • Juan Luis Santos
    • 1
    Email author
  • Julia Martín
    • 1
  • Irene Aparicio
    • 1
  • Esteban Alonso
    • 1
  1. 1.Departamento de Química Analítica, Escuela Politécnica SuperiorUniversidad de SevillaSevillaSpain

Personalised recommendations